224 related articles for article (PubMed ID: 27506957)
1. Correlations of Promoter Methylation in WIF-1, RASSF1A, and CDH13 Genes with the Risk and Prognosis of Esophageal Cancer.
Guo Q; Wang HB; Li YH; Li HF; Li TT; Zhang WX; Xiang SS; Sun ZQ
Med Sci Monit; 2016 Aug; 22():2816-24. PubMed ID: 27506957
[TBL] [Abstract][Full Text] [Related]
2. Methylation of RASSF1A and CDH13 genes in individualized chemotherapy for patients with non-small cell lung cancer.
Zhai X; Li SJ
Asian Pac J Cancer Prev; 2014; 15(12):4925-8. PubMed ID: 24998565
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Role of RASSF1A, SOX17 and Wif-1 Promoter Methylation Status in Cell-Free DNA of Advanced Gastric Cancer Patients.
Karamitrousis EI; Balgkouranidou I; Xenidis N; Amarantidis K; Biziota E; Koukaki T; Trypsianis G; Karayiannakis A; Bolanaki H; Kolios G; Lianidou E; Kakolyris S
Technol Cancer Res Treat; 2021; 20():1533033820973279. PubMed ID: 33928818
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer.
Mao WM; Li P; Zheng QQ; Wang CC; Ge MH; Hu FJ; Fang XH; Dong ZM; Ling ZQ
Arch Med Res; 2011 Apr; 42(3):182-8. PubMed ID: 21722812
[TBL] [Abstract][Full Text] [Related]
5. Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathologic characteristics of primary non-small-cell lung carcinoma.
Kontic M; Stojsic J; Jovanovic D; Bunjevacki V; Ognjanovic S; Kuriger J; Puumala S; Nelson HH
Clin Lung Cancer; 2012 Jul; 13(4):297-303. PubMed ID: 22169480
[TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
[TBL] [Abstract][Full Text] [Related]
7. Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome.
Xu J; Shetty PB; Feng W; Chenault C; Bast RC; Issa JP; Hilsenbeck SG; Yu Y
BMC Cancer; 2012 Jun; 12():243. PubMed ID: 22695491
[TBL] [Abstract][Full Text] [Related]
8. Promoter methylation and mRNA expression of DKK-3 and WIF-1 in hepatocellular carcinoma.
Ding Z; Qian YB; Zhu LX; Xiong QR
World J Gastroenterol; 2009 Jun; 15(21):2595-601. PubMed ID: 19496188
[TBL] [Abstract][Full Text] [Related]
9. Promoter methylation of WNT inhibitory factor-1 may be associated with the pathogenesis of multiple human tumors.
Zhou Y; Li Z; Ding Y; Zhang P; Wang J; Zhang J; Wang H
J Cancer Res Ther; 2018 Jun; 14(Supplement):S381-S387. PubMed ID: 29970693
[TBL] [Abstract][Full Text] [Related]
10. Methylation of RASSF1A gene promoter and the correlation with DNMT1 expression that may contribute to esophageal squamous cell carcinoma.
Du Z; Ma K; Sun X; Li A; Wang H; Zhang L; Lin F; Feng X; Song J
World J Surg Oncol; 2015 Apr; 13():141. PubMed ID: 25886188
[TBL] [Abstract][Full Text] [Related]
11. Polymorphism of A133S and promoter hypermethylation in Ras association domain family 1A gene (RASSF1A) is associated with risk of esophageal and gastric cardia cancers in Chinese population from high incidence area in northern China.
Zhou SL; Cui J; Fan ZM; Li XM; Li JL; Liu BC; Zhang DY; Liu HY; Zhao XK; Song X; Wang R; Yan ZC; Yi HX; Wang LD
BMC Cancer; 2013 May; 13():259. PubMed ID: 23705663
[TBL] [Abstract][Full Text] [Related]
12. Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma.
Kohno H; Amatya VJ; Takeshima Y; Kushitani K; Hattori N; Kohno N; Inai K
Oncol Rep; 2010 Aug; 24(2):423-31. PubMed ID: 20596629
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of Wnt inhibitory factor-1 expression in hepatocellular carcinoma that is independent of gene methylation.
Huang L; Li MX; Wang L; Li BK; Chen GH; He LR; Xu L; Yuan YF
Tumour Biol; 2011 Feb; 32(1):233-40. PubMed ID: 21052890
[TBL] [Abstract][Full Text] [Related]
14. Loss of WIF-1 and Wnt5a expression is related to aggressiveness of sporadic breast cancer in Tunisian patients.
Trifa F; Karray-Chouayekh S; Jmal E; Jmaa ZB; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
Tumour Biol; 2013 Jun; 34(3):1625-33. PubMed ID: 23417837
[TBL] [Abstract][Full Text] [Related]
15. WNT inhibitory factor 1 promoter hypermethylation is an early event during gallbladder cancer tumorigenesis that predicts poor survival.
Lin B; Hong H; Jiang X; Li C; Zhu S; Tang N; Wang X; She F; Chen Y
Gene; 2017 Jul; 622():42-49. PubMed ID: 28438695
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of the p16 and Wif-1 genes as an independent prognostic marker in stage IA non-small cell lung cancers.
Yoshino M; Suzuki M; Tian L; Moriya Y; Hoshino H; Okamoto T; Yoshida S; Shibuya K; Yoshino I
Int J Oncol; 2009 Nov; 35(5):1201-9. PubMed ID: 19787276
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of WIF-1 by hypermethylation in astrocytomas.
Yang Z; Wang Y; Fang J; Chen F; Liu J; Wu J; Wang Y; Song T; Zeng F; Rao Y
Acta Biochim Biophys Sin (Shanghai); 2010 Jun; 42(6):418-25. PubMed ID: 20539942
[TBL] [Abstract][Full Text] [Related]
18. [Methylation status of JunB and CDH13 gene promoter in CD34(+)CD38(-) chronic myelogenous leukemia cells].
Wang XJ; Li J; Fu BJ; Guo LL; Zhang JH; Huang SA
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1405-8. PubMed ID: 20030915
[TBL] [Abstract][Full Text] [Related]
19. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.
Kim JS; Chae Y; Ha YS; Kim IY; Byun SS; Yun SJ; Kim WJ
Clin Genitourin Cancer; 2012 Jun; 10(2):114-20. PubMed ID: 22382007
[TBL] [Abstract][Full Text] [Related]
20. Screening and identification of a tumor specific methylation phenotype in the colorectal laterally spreading tumor.
Ni HB; Wang FY; Xu J; He XJ; Chen J; Wu Q; Wu JF; Sun YS
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2611-2616. PubMed ID: 28678324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
